11:22 AM EST, 11/12/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking sharply lower late Tuesday morning, declining 1.71% to 1,313.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical company Cellectis ( CLLS ) , which rose 4.4% and 1.1% respectively. They were followed by accommodations booking platform trivago (TRVG), which rose 0.6%.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which fell 1.7% and 3.7% respectively. They were followed by oil and gas company TotalEnergies (TTE) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 3.2% and 2.6% respectively.

From the UK and Ireland, the gainers were led by software firm Endava ( DAVA ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which advanced 7.4% and 2.5% respectively. They were followed by biopharmaceutical companies NuCana ( NCNA ) and TC Biopharm ( TCBP ) , which increased 2% and 1.9% respectively.

The decliners from the UK and Ireland were led by telecommunications operator Vodafone Group ( VOD ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which lost 7.9% and 5.1% respectively. They were followed by insurance firm Prudential (PUK) and pharmaceutical Silence Therapeutics ( SLN ) , which dropped 5% and 4% respectively.